$PTCT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PTC THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PTC THERAPEUTICS, INC.. Get notifications about new insider transactions in PTC THERAPEUTICS, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2021 | PTCT | PTC THERAPEUTICS, ... | Smith Mary L. | Director | Option Exercise | A | 42.95 | 5,834 | 250,570 | 5,834 | |
| Jun 15 2021 | PTCT | PTC THERAPEUTICS, ... | Smith Mary L. | Director | Option Exercise | A | 42.95 | 10,000 | 429,500 | 10,000 | |
| Jun 15 2021 | PTCT | PTC THERAPEUTICS, ... | Smith Mary L. | Director | Grant | A | 0.00 | 963 | 0 | 2,613 | 1.7 K to 2.6 K (+58.36 %) |
| Jun 15 2021 | PTCT | PTC THERAPEUTICS, ... | Smith Mary L. | Director | Grant | A | 0.00 | 1,650 | 0 | 1,650 | 0 to 1.7 K |
| Apr 21 2021 | PTCT | PTC THERAPEUTICS, ... | Pauwels Eric | Chief Business Offi ... | Sell | S | 48.17 | 786 | 37,860 | 35,701 | 36.5 K to 35.7 K (-2.15 %) |
| Apr 21 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Sell | S | 47.92 | 197 | 9,440 | 16,809 | 17 K to 16.8 K (-1.16 %) |
| Apr 21 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Sell | S | 46.58 | 1,444 | 67,264 | 17,006 | 18.5 K to 17 K (-7.83 %) |
| Apr 21 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Sell | S | 48.17 | 859 | 41,376 | 18,450 | 19.3 K to 18.5 K (-4.45 %) |
| Apr 15 2021 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Grant | A | 0.00 | 1,400 | 0 | 16,481 | 15.1 K to 16.5 K (+9.28 %) |
| Apr 15 2021 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Grant | A | 0.00 | 1,400 | 0 | 16,481 | 15.1 K to 16.5 K (+9.28 %) |
| Feb 03 2021 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 57.64 | 652 | 37,581 | 16,509 | 17.2 K to 16.5 K (-3.80 %) |
| Feb 03 2021 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 56.96 | 368 | 20,960 | 17,161 | 17.5 K to 17.2 K (-2.10 %) |
| Jan 27 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 62.05 | 44 | 2,730 | 1,847 | 1.9 K to 1.8 K (-2.33 %) |
| Jan 27 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 63.25 | 497 | 31,435 | 1,891 | 2.4 K to 1.9 K (-20.81 %) |
| Jan 27 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Sell | S | 62.05 | 275 | 17,065 | 23,847 | 24.1 K to 23.8 K (-1.14 %) |
| Jan 27 2021 | PTCT | PTC THERAPEUTICS, ... | Pauwels Eric | Chief Business Offi ... | Sell | S | 62.05 | 431 | 26,745 | 36,849 | 37.3 K to 36.8 K (-1.16 %) |
| Jan 27 2021 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 62.05 | 350 | 21,719 | 15,364 | 15.7 K to 15.4 K (-2.23 %) |
| Jan 20 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Option Exercise | M | 38.98 | 4,300 | 167,614 | 86,314 | |
| Jan 20 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Sell | S | 69.09 | 4,300 | 297,078 | 19,309 | 23.6 K to 19.3 K (-18.21 %) |
| Jan 20 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Buy | M | 38.98 | 4,300 | 167,614 | 23,609 | 19.3 K to 23.6 K (+22.27 %) |
| Jan 15 2021 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 18.01 | 2,500 | 45,025 | 10,000 | |
| Jan 15 2021 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 11.23 | 788 | 8,849 | 0 | |
| Jan 15 2021 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 66.57 | 2,500 | 166,425 | 17,529 | 20 K to 17.5 K (-12.48 %) |
| Jan 15 2021 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 18.01 | 2,500 | 45,025 | 20,029 | 17.5 K to 20 K (+14.26 %) |
| Jan 15 2021 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 66.57 | 788 | 52,457 | 17,529 | 18.3 K to 17.5 K (-4.30 %) |
| Jan 15 2021 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 11.23 | 788 | 8,849 | 18,317 | 17.5 K to 18.3 K (+4.50 %) |
| Jan 15 2021 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 66.57 | 659 | 43,870 | 17,529 | 18.2 K to 17.5 K (-3.62 %) |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | M | 27.05 | 1,300 | 35,165 | 0 | |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 69.00 | 1,300 | 89,700 | 2,388 | 3.7 K to 2.4 K (-35.25 %) |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Buy | M | 27.05 | 1,300 | 35,165 | 3,688 | 2.4 K to 3.7 K (+54.44 %) |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Option Exercise | M | 38.98 | 5,500 | 214,390 | 90,614 | |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Sell | S | 70.32 | 1,500 | 105,486 | 19,309 | 20.8 K to 19.3 K (-7.21 %) |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Sell | S | 69.48 | 4,000 | 277,924 | 20,809 | 24.8 K to 20.8 K (-16.12 %) |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Buy | M | 38.98 | 5,500 | 214,390 | 24,809 | 19.3 K to 24.8 K (+28.48 %) |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Option Exercise | M | 33.02 | 9,278 | 306,360 | 11,932 | |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Option Exercise | M | 18.01 | 10,500 | 189,105 | 3,500 | |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Option Exercise | M | 11.23 | 3,825 | 42,955 | 0 | |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Option Exercise | M | 30.86 | 2,430 | 74,990 | 0 | |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Sell | S | 69.75 | 9,278 | 647,141 | 24,122 | 33.4 K to 24.1 K (-27.78 %) |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Buy | M | 33.02 | 9,278 | 306,360 | 33,400 | 24.1 K to 33.4 K (+38.46 %) |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Sell | S | 69.75 | 10,500 | 732,375 | 24,122 | 34.6 K to 24.1 K (-30.33 %) |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Buy | M | 18.01 | 10,500 | 189,105 | 34,622 | 24.1 K to 34.6 K (+43.53 %) |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Sell | S | 69.75 | 3,825 | 266,794 | 24,122 | 27.9 K to 24.1 K (-13.69 %) |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Buy | M | 11.23 | 3,825 | 42,955 | 27,947 | 24.1 K to 27.9 K (+15.86 %) |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Sell | S | 69.75 | 2,430 | 169,493 | 24,122 | 26.6 K to 24.1 K (-9.15 %) |
| Jan 12 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Buy | M | 30.86 | 2,430 | 74,990 | 26,552 | 24.1 K to 26.6 K (+10.07 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Option Exercise | A | 66.49 | 63,000 | 4,188,870 | 63,000 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Grant | A | 0.00 | 10,800 | 0 | 24,122 | 13.3 K to 24.1 K (+81.07 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | A | 66.49 | 59,500 | 3,956,155 | 59,500 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Grant | A | 0.00 | 10,200 | 0 | 49,152 | 39 K to 49.2 K (+26.19 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Pauwels Eric | Chief Business Offi ... | Option Exercise | A | 66.49 | 59,500 | 3,956,155 | 59,500 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Pauwels Eric | Chief Business Offi ... | Grant | A | 0.00 | 10,200 | 0 | 37,280 | 27.1 K to 37.3 K (+37.67 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | A | 66.49 | 23,100 | 1,535,919 | 23,100 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | A | 66.49 | 161,000 | 10,704,890 | 161,000 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Grant | A | 0.00 | 3,960 | 0 | 15,714 | 11.8 K to 15.7 K (+33.69 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Grant | A | 0.00 | 27,600 | 0 | 82,283 | 54.7 K to 82.3 K (+50.47 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | A | 66.49 | 50,750 | 3,374,368 | 50,750 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Grant | A | 0.00 | 8,700 | 0 | 18,188 | 9.5 K to 18.2 K (+91.69 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Option Exercise | M | 39.98 | 3,886 | 155,362 | 96,114 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Option Exercise | A | 66.49 | 52,500 | 3,490,725 | 52,500 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Sell | S | 68.98 | 3,886 | 268,056 | 19,309 | 23.2 K to 19.3 K (-16.75 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Buy | M | 38.98 | 3,886 | 151,476 | 23,195 | 19.3 K to 23.2 K (+20.13 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Klein Matthew B. | Chief Development O ... | Grant | A | 0.00 | 9,000 | 0 | 19,309 | 10.3 K to 19.3 K (+87.30 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | A | 66.49 | 59,500 | 3,956,155 | 59,500 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Grant | A | 0.00 | 600 | 0 | 2,388 | 1.8 K to 2.4 K (+33.56 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Grant | A | 0.00 | 10,200 | 0 | 36,787 | 26.6 K to 36.8 K (+38.36 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Option Exercise | A | 66.49 | 10,000 | 664,900 | 10,000 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Grant | A | 0.00 | 1,650 | 0 | 4,328 | 2.7 K to 4.3 K (+61.61 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Option Exercise | A | 66.49 | 10,000 | 664,900 | 10,000 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Grant | A | 0.00 | 1,650 | 0 | 27,936 | 26.3 K to 27.9 K (+6.28 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Option Exercise | A | 66.49 | 10,000 | 664,900 | 10,000 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Grant | A | 0.00 | 1,650 | 0 | 5,148 | 3.5 K to 5.1 K (+47.17 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Option Exercise | A | 66.49 | 10,000 | 664,900 | 10,000 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Grant | A | 0.00 | 1,650 | 0 | 3,300 | 1.7 K to 3.3 K (+100.00 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Okey Stephanie | Director | Option Exercise | A | 66.49 | 10,000 | 664,900 | 10,000 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | Okey Stephanie | Director | Grant | A | 0.00 | 1,650 | 0 | 2,613 | 963 to 2.6 K (+171.34 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 66.49 | 10,000 | 664,900 | 10,000 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Grant | A | 0.00 | 1,650 | 0 | 3,300 | 1.7 K to 3.3 K (+100.00 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | STEELE GLENN JR MD PHD | Director | Option Exercise | A | 66.49 | 10,000 | 664,900 | 10,000 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | STEELE GLENN JR MD PHD | Director | Grant | A | 0.00 | 1,650 | 0 | 3,300 | 1.7 K to 3.3 K (+100.00 %) |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Option Exercise | A | 66.49 | 20,000 | 1,329,800 | 20,000 | |
| Jan 08 2021 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Grant | A | 0.00 | 3,300 | 0 | 103,366 | 100.1 K to 103.4 K (+3.30 %) |
| Jan 07 2021 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 62.37 | 772 | 48,150 | 38,952 | 39.7 K to 39 K (-1.94 %) |
| Jan 07 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Sell | S | 62.37 | 176 | 10,977 | 13,322 | 13.5 K to 13.3 K (-1.30 %) |
| Jan 07 2021 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Sell | S | 62.37 | 112 | 6,985 | 13,498 | 13.6 K to 13.5 K (-0.82 %) |
| Jan 07 2021 | PTCT | PTC THERAPEUTICS, ... | Pauwels Eric | Chief Business Offi ... | Sell | S | 62.37 | 778 | 48,524 | 27,080 | 27.9 K to 27.1 K (-2.79 %) |
| Jan 07 2021 | PTCT | PTC THERAPEUTICS, ... | Pauwels Eric | Chief Business Offi ... | Sell | S | 62.37 | 289 | 18,025 | 27,858 | 28.1 K to 27.9 K (-1.03 %) |
| Jan 07 2021 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 62.37 | 382 | 23,825 | 11,754 | 12.1 K to 11.8 K (-3.15 %) |
| Jan 07 2021 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 62.37 | 284 | 17,713 | 12,136 | 12.4 K to 12.1 K (-2.29 %) |
| Jan 07 2021 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 62.37 | 1,402 | 87,443 | 54,683 | 56.1 K to 54.7 K (-2.50 %) |
| Jan 07 2021 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 62.37 | 316 | 19,709 | 9,488 | 9.8 K to 9.5 K (-3.22 %) |
| Jan 07 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 62.37 | 68 | 4,241 | 1,788 | 1.9 K to 1.8 K (-3.66 %) |
| Jan 07 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 62.37 | 56 | 3,493 | 1,856 | 1.9 K to 1.9 K (-2.93 %) |
| Jan 07 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 62.37 | 502 | 31,310 | 26,587 | 27.1 K to 26.6 K (-1.85 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | M | 10.85 | 600 | 6,510 | 0 | |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | M | 18.01 | 48,125 | 866,731 | 17,500 | |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | M | 18.01 | 187 | 3,368 | 65,625 | |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | M | 11.23 | 5,715 | 64,179 | 0 | |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | M | 18.01 | 4,188 | 75,426 | 65,812 | |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | M | 11.23 | 2,188 | 24,571 | 5,715 | |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | M | 11.23 | 3,035 | 34,083 | 7,903 | |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | M | 27.05 | 32,771 | 886,456 | 0 | |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | M | 27.05 | 7,229 | 195,544 | 32,771 | |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 60.65 | 600 | 36,390 | 1,912 | 2.5 K to 1.9 K (-23.89 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Buy | M | 10.85 | 600 | 6,510 | 2,512 | 1.9 K to 2.5 K (+31.38 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 61.24 | 189 | 11,574 | 27,089 | 27.3 K to 27.1 K (-0.69 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 60.58 | 47,936 | 2,903,723 | 27,278 | 75.2 K to 27.3 K (-63.73 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Buy | M | 18.01 | 48,125 | 866,731 | 75,214 | 27.1 K to 75.2 K (+177.66 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 60.61 | 187 | 11,334 | 27,089 | 27.3 K to 27.1 K (-0.69 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Buy | M | 18.01 | 187 | 3,368 | 27,276 | 27.1 K to 27.3 K (+0.69 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 61.24 | 100 | 6,124 | 27,089 | 27.2 K to 27.1 K (-0.37 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 60.56 | 5,615 | 340,044 | 27,189 | 32.8 K to 27.2 K (-17.12 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Buy | M | 11.23 | 5,715 | 64,179 | 32,804 | 27.1 K to 32.8 K (+21.10 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 60.59 | 4,188 | 253,743 | 27,089 | 31.3 K to 27.1 K (-13.39 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Buy | M | 18.01 | 4,188 | 75,426 | 31,277 | 27.1 K to 31.3 K (+15.46 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 60.54 | 2,188 | 132,466 | 27,089 | 29.3 K to 27.1 K (-7.47 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Buy | M | 11.23 | 2,188 | 24,571 | 29,277 | 27.1 K to 29.3 K (+8.08 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 61.36 | 100 | 6,136 | 27,089 | 27.2 K to 27.1 K (-0.37 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 60.56 | 2,935 | 177,741 | 27,189 | 30.1 K to 27.2 K (-9.74 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Buy | M | 11.23 | 3,035 | 34,083 | 30,124 | 27.1 K to 30.1 K (+11.20 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 61.25 | 200 | 12,249 | 27,089 | 27.3 K to 27.1 K (-0.73 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 60.58 | 32,571 | 1,973,021 | 27,289 | 59.9 K to 27.3 K (-54.41 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Buy | M | 27.05 | 32,771 | 886,456 | 59,860 | 27.1 K to 59.9 K (+120.98 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 60.59 | 7,229 | 438,012 | 27,089 | 34.3 K to 27.1 K (-21.06 %) |
| Jan 06 2021 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Buy | M | 27.05 | 7,229 | 195,544 | 34,318 | 27.1 K to 34.3 K (+26.69 %) |
| Dec 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 33.02 | 115,937 | 3,828,240 | 149,063 | |
| Dec 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 30.86 | 169,781 | 5,239,442 | 5,219 | |
| Dec 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 63.25 | 7,938 | 502,047 | 56,085 | 64 K to 56.1 K (-12.40 %) |
| Dec 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 62.27 | 30,060 | 1,871,776 | 64,023 | 94.1 K to 64 K (-31.95 %) |
| Dec 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 61.43 | 77,939 | 4,787,793 | 94,083 | 172 K to 94.1 K (-45.31 %) |
| Dec 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 33.02 | 115,937 | 3,828,240 | 172,022 | 56.1 K to 172 K (+206.72 %) |
| Dec 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 63.19 | 8,212 | 518,924 | 56,085 | 64.3 K to 56.1 K (-12.77 %) |
| Dec 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 62.34 | 38,779 | 2,417,560 | 64,297 | 103.1 K to 64.3 K (-37.62 %) |
| Dec 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 61.43 | 122,790 | 7,543,358 | 103,076 | 225.9 K to 103.1 K (-54.36 %) |
| Dec 31 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 30.86 | 169,781 | 5,239,442 | 225,866 | 56.1 K to 225.9 K (+302.72 %) |
| Dec 16 2020 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Option Exercise | M | 33.02 | 1,028 | 33,945 | 11,000 | |
| Dec 16 2020 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Option Exercise | M | 33.02 | 972 | 32,095 | 12,028 | |
| Dec 16 2020 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Option Exercise | M | 33.02 | 1,000 | 33,020 | 13,000 | |
| Dec 16 2020 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Buy | M | 33.02 | 1,028 | 33,945 | 2,678 | 1.7 K to 2.7 K (+62.30 %) |
| Dec 16 2020 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Sell | S | 68.00 | 972 | 66,096 | 1,650 | 2.6 K to 1.7 K (-37.07 %) |
| Dec 16 2020 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Buy | M | 33.02 | 972 | 32,095 | 2,622 | 1.7 K to 2.6 K (+58.91 %) |
| Dec 16 2020 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Sell | S | 68.00 | 1,000 | 68,000 | 1,650 | 2.7 K to 1.7 K (-37.74 %) |
| Dec 16 2020 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Buy | M | 33.02 | 1,000 | 33,020 | 2,650 | 1.7 K to 2.7 K (+60.61 %) |
| Dec 10 2020 | PTCT | PTC THERAPEUTICS, ... | Okey Stephanie | Director | Sell | S | 62.52 | 687 | 42,954 | 963 | 1.7 K to 963 (-41.64 %) |
| Dec 09 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 27.05 | 7,208 | 194,976 | 192,792 | |
| Dec 09 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 10.85 | 3,104 | 33,678 | 0 | |
| Dec 09 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 10.85 | 2,115 | 22,948 | 0 | |
| Dec 09 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 10.85 | 7,590 | 82,352 | 3,104 | |
| Dec 09 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 64.82 | 700 | 45,374 | 56,085 | 56.8 K to 56.1 K (-1.23 %) |
| Dec 09 2020 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 64.16 | 1,200 | 76,992 | 56,785 | 58 K to 56.8 K (-2.07 %) |